Nate Chin
speaker
95 appearances
1 recordings
1 series
first heard Aug 2023
last heard Aug 2023
Nate Chin’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
In clinic, we don't have the ability as of now to do the biological identification on everyone.
And that speaks to Sharon's point, this access issue.
We're not that that point where every person can have blood or that we all trust the blood.
So the syndrome still matters.
So we still have MCI, we still have dementia.
But I do like this idea of diagnosing or defining, I don't want to use the word diagnosing, defining Alzheimer's biology, where I don't think we're there quite yet, is we really need our longitudinal studies to tell us that there is no such thing as benign amyloid.
If you could tell me that every person with elevated or considered abnormal amyloid progresses.
To tau.
Then I would say it makes sense to me because then amyloid and tau do really come together, these hallmarks pathologically, as Alzheimer's disease.
But I just haven't seen that.
I haven't seen this clear direct relationship that all abnormally high levels of amyloid lead to tau.
I think there's there's probably that building data.
But until you show me that as a clinician.
You I feel like we've gone out on a limb here and just said elevated amyloid is eventually gonna lead to disease.
I would say I would want every geriatrician to weigh in on the conversation and to take a lead in being a part of of memory care, whether it's in your primary care or in a specialty care, that they would have a a seat at the table with every other specialist.
Showing 81–95 of 95 · page 5 of 5
← Previous